IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GREGORY D FERGUSON

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1588205660
CMS profile
11076906
Location
KATY, TX

General Payments · PY2021–2024

$5,046.71

  • Reported across 241 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,345.51

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,327.80 51
Education $17.71 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $257.70 12
Octapharma USA, Inc. $251.48 1
GlaxoSmithKline, LLC. $201.86 11
Regeneron Healthcare Solutions, Inc. $137.81 8
Blueprint Medicines Corporation $122.76 4
GENZYME CORPORATION $104.48 4
Takeda Pharmaceuticals U.S.A., Inc. $88.77 3
NOVARTIS PHARMACEUTICALS CORPORATION $39.40 2
Phadia US Inc. $24.98 1
Kaleo, Inc. $23.30 1
Amgen Inc. $21.62 1
Incyte Corporation $20.97 1
Genentech USA, Inc. $18.42 1
CSL Behring $17.12 1
OptiNose US, Inc. $14.84 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,276.06 73
PY2022 $1,191.43 59
PY2023 $1,233.71 57
PY2024 $1,345.51 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.62 09/11/2024 Food and Beverage Undisputed 01/23/2026 1115621576 CMS
AstraZeneca Pharmaceuticals LP $26.78 01/09/2024 Food and Beverage Undisputed 01/23/2026 1104751370 CMS
AstraZeneca Pharmaceuticals LP $23.76 01/30/2024 Food and Beverage Undisputed 01/23/2026 1105213649 CMS
AstraZeneca Pharmaceuticals LP $20.16 02/05/2024 Food and Beverage Undisputed 01/23/2026 1105723643 CMS
AstraZeneca Pharmaceuticals LP $19.54 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104224785 CMS
AstraZeneca Pharmaceuticals LP $18.19 03/22/2024 Food and Beverage Undisputed 01/23/2026 1105524577 CMS
AstraZeneca Pharmaceuticals LP $21.66 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104599136 CMS
AstraZeneca Pharmaceuticals LP $23.28 07/01/2024 Food and Beverage Undisputed 01/23/2026 1104522818 CMS
AstraZeneca Pharmaceuticals LP $19.35 07/24/2024 Food and Beverage Undisputed 01/23/2026 1104225541 CMS
AstraZeneca Pharmaceuticals LP $17.99 08/12/2024 Food and Beverage Undisputed 01/23/2026 1105859862 CMS
AstraZeneca Pharmaceuticals LP $23.25 10/08/2024 Food and Beverage Undisputed 01/23/2026 1104367667 CMS
AstraZeneca Pharmaceuticals LP $21.87 11/05/2024 Food and Beverage Undisputed 01/23/2026 1104646571 CMS
AstraZeneca Pharmaceuticals LP $21.87 12/11/2024 Food and Beverage Undisputed 01/23/2026 1104347238 CMS
Blueprint Medicines Corporation $26.39 02/20/2024 Food and Beverage Undisputed 01/23/2026 1147456025 CMS
Blueprint Medicines Corporation $26.96 04/23/2024 Food and Beverage Undisputed 01/23/2026 1147456055 CMS
Blueprint Medicines Corporation $31.61 08/09/2024 Food and Beverage Undisputed 01/23/2026 1147456099 CMS
Blueprint Medicines Corporation $37.80 10/23/2024 Food and Beverage Undisputed 01/23/2026 1147456123 CMS
CSL Behring $17.12 03/19/2024 Food and Beverage Undisputed 01/23/2026 1134629783 CMS
Genentech USA, Inc. $18.42 07/24/2024 Food and Beverage Undisputed 01/23/2026 1133159722 CMS
GENZYME CORPORATION $29.64 04/22/2024 Food and Beverage Undisputed 01/23/2026 1139962825 CMS
GENZYME CORPORATION $31.19 05/22/2024 Food and Beverage Undisputed 01/23/2026 1139962827 CMS
GENZYME CORPORATION $23.86 07/31/2024 Food and Beverage Undisputed 01/23/2026 1139962861 CMS
GENZYME CORPORATION $19.79 12/02/2024 Food and Beverage Undisputed 01/23/2026 1139962893 CMS
GlaxoSmithKline, LLC. $16.85 01/17/2024 Food and Beverage Undisputed 01/23/2026 1116622497 CMS
GlaxoSmithKline, LLC. $11.99 07/30/2024 Food and Beverage Undisputed 01/23/2026 1116104929 CMS
GlaxoSmithKline, LLC. $25.11 09/05/2024 Food and Beverage Undisputed 01/23/2026 1115843181 CMS
GlaxoSmithKline, LLC. $16.80 09/13/2024 Food and Beverage Undisputed 01/23/2026 1116186651 CMS
GlaxoSmithKline, LLC. $32.25 10/01/2024 Food and Beverage Undisputed 01/23/2026 1116299534 CMS
GlaxoSmithKline, LLC. $20.87 10/17/2024 Food and Beverage Undisputed 01/23/2026 1115909123 CMS
GlaxoSmithKline, LLC. $15.05 10/18/2024 Food and Beverage Undisputed 01/23/2026 1116295437 CMS
GlaxoSmithKline, LLC. $17.66 11/14/2024 Food and Beverage Undisputed 01/23/2026 1116647935 CMS
GlaxoSmithKline, LLC. $10.53 12/05/2024 Food and Beverage Undisputed 01/23/2026 1116211954 CMS
GlaxoSmithKline, LLC. $24.85 12/06/2024 Food and Beverage Undisputed 01/23/2026 1116569389 CMS
GlaxoSmithKline, LLC. $9.90 12/11/2024 Food and Beverage Undisputed 01/23/2026 1116310991 CMS
Incyte Corporation $20.97 08/07/2024 Food and Beverage Undisputed 01/23/2026 1141249572 CMS
kaleo, Inc. $23.30 01/15/2024 Food and Beverage Undisputed 01/23/2026 1126632608 CMS
Novartis Pharmaceuticals Corporation $22.26 02/08/2024 Food and Beverage Undisputed 01/23/2026 1086823955 CMS
Novartis Pharmaceuticals Corporation $17.14 10/07/2024 Food and Beverage Undisputed 01/23/2026 1086823991 CMS
Octapharma USA, Inc. $251.48 01/27/2024 Food and Beverage Undisputed 01/23/2026 1142321829 CMS
Optinose US, Inc. $14.84 08/08/2024 Food and Beverage Undisputed 01/23/2026 1142193812 CMS
Phadia US Inc. $24.98 08/26/2024 Food and Beverage Undisputed 01/23/2026 1067579200 CMS
Regeneron Healthcare Solutions, Inc. $17.71 02/08/2024 Education Undisputed 01/23/2026 1114300119 CMS
Regeneron Healthcare Solutions, Inc. $7.10 02/08/2024 Food and Beverage Undisputed 01/23/2026 1114300121 CMS
Regeneron Healthcare Solutions, Inc. $29.76 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114300123 CMS
Regeneron Healthcare Solutions, Inc. $33.16 06/04/2024 Food and Beverage Undisputed 01/23/2026 1114300125 CMS
Regeneron Healthcare Solutions, Inc. $23.86 08/13/2024 Food and Beverage Undisputed 01/23/2026 1114300127 CMS
Regeneron Healthcare Solutions, Inc. $7.45 10/10/2024 Food and Beverage Undisputed 01/23/2026 1114300129 CMS
Regeneron Healthcare Solutions, Inc. $8.81 11/12/2024 Food and Beverage Undisputed 01/23/2026 1114300131 CMS
Regeneron Healthcare Solutions, Inc. $9.96 12/11/2024 Food and Beverage Undisputed 01/23/2026 1114300133 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.31 02/07/2024 Food and Beverage Undisputed 01/23/2026 1137742060 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.01 02/14/2024 Food and Beverage Undisputed 01/23/2026 1137742062 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.45 06/05/2024 Food and Beverage Undisputed 01/23/2026 1137742064 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.